Investing Profile

Leen Kawas

InvestorVC
Managing General Partner at Propel Bio Partners LLC
propelbio.comSeattle, Washington
Photo of Leen Kawas, General Partner at Propel Bio Partners LLC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Washington Network
123 CONNECTIONS
Chief Network
42 CONNECTIONS
Nucleate Network
27 CONNECTIONS
Forbes Business Council Network
24 CONNECTIONS
Forbes Real Estate Council Network
17 CONNECTIONS
Propel Bio Partners LLC General Partner
$100K - $5.0M
$1.5M
Board Observer NOWDiagnostics | NOWDx2023 - Present
Member Board of Directors Inherent Biosciences, Inc.2022 - Present
Advisor-Seattle Nucleate2022 - Present
Member Board Of Directors Persephone Biosciences2022 - Present
Member Chief2022 - Present
Managing General Partner Propel Bio Partners LLC2021 - Present
Clinical Pharmacist DUSC CORPORATE ANALYSTSPresent
Staff Pharmacist DUSC CORPORATE ANALYSTSPresent
Research Associate Washington State University SpokanePresent
Member Board Of Directors Persephone BiomePresent
Member Forbes Real Estate CouncilPresent
Board Observer- Investor TympanogenPresent
Mentor WASHINGTON INNOVATION NETWORKPresent
CEO & President LeonaBioPresent
Managing General Partner Propel Bio PartnersPresent
Chief Executive Officer EIT Pharma, Inc.Present
Member Forbes Business Council2022 - 2025
CEO & President Athira Pharma2014 - 2021
Research Associate Washington State University2013 - 2015
Vice President of Research Athira Pharma2011 - 2014
Staff Pharmacist Pharmacy1, Amman Jordan2008 - 2008
Clinical Pharmacist University of Jordan Hospital2007 - 2008
Wharton Executive Education Investment Strategies and Portfolio Management
University of Washington Executive Education Foster School of Business
Washington State University PhD molecular pharmacology & toxicology
University of Jordan Pharmacy
Sign in with Google →
Sign in with Google →